✦ LIBER ✦

Systematic review of systemic adjuvant therapy for patients at high risk for recurrent melanoma

✍ Scribed by Shailendra Verma; Ian Quirt; David McCready; Kate Bak; Manya Charette; Neill Iscoe; Melanoma Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 174 KB
Volume: 106
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.21760

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The risk of venous thromboembolic diseas

The risk of venous thromboembolic disease associated with adjuvant hormone therapy for breast carcinoma : A systematic review

✍ Steven R. Deitcher; Marcelo P. V. Gomes 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB 👁 1 views

## Background: Tamoxifen therapy for patients with breast carcinoma is perceived as an independent risk factor for venous thromboembolic events (vte), but the risk associated with other adjuvant therapies is less well recognized. ## Methods: The authors conducted a computerized pubmed literature

Prevention of local-regional recurrence

Prevention of local-regional recurrence with the addition of radiation in post-mastectomy patients at high risk for local recurrence receiving adjuvant chemotherapy

✍ Barbara Fowble; John Glick; Robert Goodman 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 120 KB

The benefits of adjuvant radiation thera

The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma

✍ Shefali Agrawal; John M. Kane III; Beverly A. Guadagnolo; William G. Kraybill; M 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

Radiotherapy for the prevention of local

Radiotherapy for the prevention of local-regional recurrence in high risk patients post mastectomy receiving adjuvant chemotherapy

✍ Barbara Fowble; John Glick; Robert Goodman 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 689 KB

Formation of neutralizing antibodies aga

Formation of neutralizing antibodies against natural interferon-β, but not against recombinant interferon-γ during adjuvant therapy for high-risk malignant melanoma patients

✍ R. Dummer; W. Müller; F. Nestle; J. Wiede; J. Dues; W. Lechner; I. Haubitz; W. W 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 487 KB 👁 1 views

Quality measures for the use of adjuvant

Quality measures for the use of adjuvant chemotherapy and radiation therapy in patients with colorectal cancer : A systematic review

✍ Robert G. Prosnitz; Meenal B. Patwardhan; Gregory P. Samsa; Christopher R. Manty 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 1 views